The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial
Open accessAbstract
OBJECTIVE: To compare the effects on proteinuria and blood pressure of addition of dietary sodium restriction or angiotensin receptor blockade at maximum dose, or their combination, in patients with non-diabetic nephropathy receiving background treatment with angiotensin converting enzyme (ACE) inhibition at maximum dose. DESIGN: Multicentre crossover randomised controlled trial. SETTING: Outpatient clinics in the Netherlands. PARTICIPANTS: 52 patients with non-diabetic nephropathy. INTERVENTIONS: All patients were treated during four 6 week periods, in random order, with angiotensin receptor blockade (valsartan 320 mg/day) or placebo, each combined with, consecutively, a low sodium diet (target 50 mmol Na(+)/day) and a regular sodium diet (target 200 mmol Na(+)/day), with a background of ACE inhibition (lisinopril 40 mg/day) during the entire study. The drug interventions were double blind; the dietary interventions were open label. MAIN OUTCOME MEASURES: The primary outcome measure was proteinuria; the secondary outcome measure was blood pressure. RESULTS: Mean urinary sodium excretion, a measure of dietary sodium intake, was 106 (SE 5) mmol Na(+)/day during a low sodium diet and 184 (6) mmol Na(+)/day during a regular sodium diet (P<0.001). Geometric mean residual proteinuria was 1.68 (95% confidence interval 1.31 to 2.14) g/day during ACE inhibition plus a regular sodium diet. Addition of angiotensin receptor blockade to ACE inhibition reduced proteinuria to 1.44 (1.07 to 1.93) g/day (P=0.003), addition of a low sodium diet reduced it to 0.85 (0.66 to 1.10) g/day (P<0.001), and addition of angiotensin receptor blockade plus a low sodium diet reduced it to 0.67 (0.50 to 0.91) g/day (P<0.001). The reduction of proteinuria by the addition of a low sodium diet to ACE inhibition (51%, 95% confidence interval 43% to 58%) was significantly larger (P<0.001) than the reduction of proteinuria by the addition of angiotensin receptor blockade to ACE inhibition (21%, (8% to 32%) and was comparable (P=0.009, not significant after Bonferroni correction) to the reduction of proteinuria by the addition of both angiotensin receptor blockade and a low sodium diet to ACE inhibition (62%, 53% to 70%). Mean systolic blood pressure was 134 (3) mm Hg during ACE inhibition plus a regular sodium diet. Mean systolic blood pressure was not significantly altered by the addition of angiotensin receptor blockade (131 (3) mm Hg; P=0.12) but was reduced by the addition of a low sodium diet (123 (2) mm Hg; P<0.001) and angiotensin receptor blockade plus a low sodium diet (121 (3) mm Hg; P<0.001) to ACE inhibition. The reduction of systolic blood pressure by the addition of a low sodium diet (7% (SE 1%)) was significantly larger (P=0.003) than the reduction of systolic blood pressure by the addition of angiotensin receptor blockade (2% (1)) and was similar (P=0.14) to the reduction of systolic blood pressure by the addition of both angiotensin receptor blockade and low sodium diet (9% (1)), to ACE inhibition. CONCLUSIONS: Dietary sodium restriction to a level recommended in guidelines was more effective than dual blockade for reduction of proteinuria and blood pressure in non-diabetic nephropathy. The findings support the combined endeavours of patients and health professionals to reduce sodium intake. Trial registration Netherlands Trial Register NTR675.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Nakao, N., Yoshimura, A., Morita, H., Takada, M., Kayano, T., & Ideura, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12229-5 · Cited by 970
Retracted- Retracted
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
Strazzullo, P., D'Elia, L., Kandala, N.-B., & Cappuccio, F. P. (2009) · BMJ · doi:10.1136/bmj.b4567 · Cited by 1,580
Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A., Hunsicker, L. G., King, A. J., Klahr, S., Massry, S. G., Seifter, J. L., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00003 · Cited by 1,342
Projected effect of dietary salt reductions on future cardiovascular disease
Bibbins-Domingo, K., Chertow, G. M., Coxson, P. G., Moran, A., Lightwood, J. M., Pletcher, M. J., & Goldman, L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907355 · Cited by 1,253
(2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.03.003 · Cited by 1,245
Cook, N. R., Cutler, J. A., Obarzanek, E., Buring, J. E., Rexrode, K. M., Kumanyika, S. K., Appel, L. J., & Whelton, P. K. (2007) · BMJ · doi:10.1136/bmj.39147.604896.55 · Cited by 1,179
Salt intakes around the world: implications for public health
Brown, I. J., Tzoulaki, I., Candeias, V., & Elliott, P. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp139 · Cited by 1,173 · cited 1×
“day, but a substantial reduction in sodium intake to values in line with the guidelines for renal patients was nevertheless achieved.”
ResultJafar, T. H., Stark, P. C., Schmid, C. H., Landa, M., Maschio, G., de Jong, P. E., de Zeeuw, D., Shahinfar, S., Toto, R., Levey, A. S., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-4-200308190-00006 · Cited by 1,157
Self-citationBakris, G. L., & Weir, M. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.685 · Cited by 823
A method for estimating nitrogen intake of patients with chronic renal failure
Maroni, B. J., Steinman, T. I., & Mitch, W. E. (1985) · Kidney International · doi:10.1038/ki.1985.10 · Cited by 780
Effect of longer-term modest salt reduction on blood pressure
He, F. J., Li, J., & MacGregor, G. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004937.pub2 · Cited by 722
Kunz, R., Friedrich, C., Wolbers, M., & Mann, J. F. E. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-1-200801010-00190 · Cited by 717
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Einhorn, L. M., Zhan, M., Hsu, V. D., Walker, L. D., Moen, M. F., Seliger, S. L., Weir, M. R., & Fink, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.132 · Cited by 646
Progression, remission, regression of chronic renal diseases
Ruggenenti, P., Schieppati, A., & Remuzzi, G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04728-0 · Cited by 554
(2004) · PubMed · Cited by 485
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
Lopez, A., & Marantz, P. R. (1994) · PubMed · Cited by 424
LEVEY, A. S., GREENE, T., BECK, G. J., CAGGIULA, A. W., KUSEK, J. W., HUNSICKER, L. G., & KLAHR, S. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10112426 · Cited by 399
Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan
Vogt, L., Waanders, F., Boomsma, F., de Zeeuw, D., & Navis, G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060693 · Cited by 372
Self-citationEfficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril
Heeg, J. E., de Jong, P. E., van der Hem, G. K., & de Zeeuw, D. (1989) · Kidney International · doi:10.1038/ki.1989.190 · Cited by 363
Effect of longer-term modest salt reduction on blood pressure
He, F. J., & MacGregor, G. A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004937 · Cited by 300
Rossing, K., Schjoedt, K. J., Jensen, B. R., Boomsma, F., & Parving, H.-H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00511.x · Cited by 225
Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study
Korgaonkar, S., Tilea, A., Gillespie, B. W., Kiser, M., Eisele, G., Finkelstein, F., Kotanko, P., Pitt, B., & Saran, R. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05850809 · Cited by 209
Apperloo, A. J., de Zeeuw, D., & de Jong, P. E. (1997) · Kidney International · doi:10.1038/ki.1997.111 · Cited by 205
Role of Remission Clinics in the Longitudinal Treatment of CKD
Ruggenenti, P., Perticucci, E., Cravedi, P., Gambara, V., Costantini, M., Sharma, S. K., Perna, A., & Remuzzi, G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007090970 · Cited by 204
Buter, H. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.7.1682 · Cited by 199
Telmisartan, Ramipril, or Both in Patients at High Risk of Vascular Events
(2008) · New England Journal of Medicine · doi:10.1056/nejmc081065 · Cited by 175
Dual renin-angiotensin system blockade at optimal doses for proteinuria
Laverman, G. D., Navis, G., Henning, R. H., De Jong, P. E., & De Zeeuw, D. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00536.x · Cited by 170
Self-citationRole of Dietary Sodium in Osteoporosis
Heaney, R. P. (2006) · Journal of the American College of Nutrition · doi:10.1080/07315724.2006.10719577 · Cited by 161
Nicola, L. D., Minutolo, R., Chiodini, P., Zoccali, C., Castellino, P., Donadio, C., Strippoli, M., Casino, F. G., Giannattasio, M., Petrarulo, F., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000085 · Cited by 135
A Low-Sodium Diet Potentiates the Effects of Losartan in Type 2 Diabetes
Houlihan, C. A., Allen, T. J., Baxter, A. L., Panangiotopoulos, S., CASLEY, D. J., Cooper, M. E., & Jerums, G. (2002) · Diabetes Care · doi:10.2337/diacare.25.4.663 · Cited by 132
Esnault, V. L. M., Ekhlas, A., Delcroix, C., Mg, M., & Nguyen, J. (2004) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060505 · Cited by 122
Salt-Induced Increases in Systolic Blood Pressure Affect Renal Hemodynamics and Proteinuria
Weir, M. R., Dengel, D. R., Behrens, M. T., & Goldberg, A. P. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1339 · Cited by 108
Pijls, L. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.6.1445 · Cited by 103
Krikken, J. A., Lely, A. T., Bakker, S. J. L., & Navis, G. J. (2006) · Kidney International · doi:10.1038/sj.ki.5002011 · Cited by 100
Self-citationMicroalbuminuria as a Target to Improve Cardiovascular and Renal Outcomes
Basi, S., & Lewis, J. D. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.02.182 · Cited by 90
Hansen, H. P., Rossing, P. R., Tarnow, L., Nielsen, F. S., Jensen, B. R., & Parving, H. (1995) · Kidney International · doi:10.1038/ki.1995.238 · Cited by 82
Catapano, F., Chiodini, P., Nicola, L. D., Minutolo, R., Zamboli, P., Gallo, C., & Conte, G. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.03.008 · Cited by 82
The precision of estimating protein intake of patients with chronic renal failure
Masud, T., Manatunga, A. K., Cotsonis, G., & Mitch, W. E. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00606.x · Cited by 79
Ekinci, E. I., Thomas, G., Thomas, D. M., Johnson, C., MacIsaac, R. J., Houlihan, C. A., Finch, S. J., Panagiotopoulos, S., O’Callaghan, C. J., & Jerums, G. (2009) · Diabetes Care · doi:10.2337/dc08-2297 · Cited by 63
van Zuilen, A. D., Wetzels, J. F. M., Bots, M. L., & Blankestijn, P. J. (2008) · Journal of Nephrology · doi:10.1093/joneph/21.3.261 · Cited by 52
ACE Inhibition versus Angiotensin Receptor Blockade
Laverman, G. D., Remuzzi, G., & Ruggenenti, P. L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093368.27046.3c · Cited by 40
Self-citationEsnault, V. L. M., Ekhlas, A., Nguyen, J., & Moranne, O. P. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp776 · Cited by 34
Dual blockade of the renin–angiotensin–aldosterone system in cardiac and renal disease
Slagman, M. C. J., Navis, G. J., & Laverman, G. D. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283361887 · Cited by 32
Self-citationPhysician Career Satisfaction Across Specialties: Are We Getting the True Picture?—Reply
Leigh, J. P., & Kravitz, R. L. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.2.244-a · Cited by 30
The salt paradox and its possible implications in managing hypertensive diabetic patients
Vallon, V., Blantz, R. C., & Thomson, S. C. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0089-x · Cited by 22
Correa, J. A., & Bellavance, F. (2001) · Statistics in Medicine · doi:10.1002/sim.776 · Cited by 16
Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease
Bibbins-Domingo, K. B., Chertow, G. M., Coxson, P. G., Moran, A. E., Lightwood, J. M., Pletcher, M. J., & Goldman, L. (2010) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3181e5f253 · Cited by 16
The assessment and management of albuminuria in primary care
Thomas, M. C. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.024 · Cited by 10
Suzuki, T., Miyazaki, Y., Shimizu, A., et al. (2009) · Clinical Nephrology · doi:10.5414/cnp72274 · Cited by 6
Cited by
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213
Self-citationKDOQI clinical practice guideline for nutrition in CKD: 2020 update
Ikizler, T. A., Burrowes, J. D., Byham-Gray, L. D., Campbell, K. L., Carrero, J.-J., Chan, W., Fouque, D., Friedman, A. N., Ghaddar, S., Goldstein-Fuchs, D. J., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.006 · Cited by 1,960
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452
Lichtenstein, A. H., Appel, L. J., Vadiveloo, M., Hu, F. B., Kris-Etherton, P. M., Rebholz, C. M., Sacks, F. M., Thorndike, A. N., Van Horn, L., Wylie-Rosett, J., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001031 · Cited by 1,065
Metadata
- Authors
- Slagman, M. C. J., Waanders, F., Hemmelder, M. H., Woittiez, A.-J., Janssen, W. M. T., Lambers Heerspink, H. J., Navis, G., Laverman, G. D., & for the HONEST (HOlland NEphrology STudy) Group
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2011-07-26
- Volume
- 343
- Issue
- jul26 2
- Pages
- d4366-d4366
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1973663762
- Cited by
- 286
- References
- 56
- FWCI
- 23.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.